CRTAC1:一个新的肺部参与SScc的指标
Aneta Prokopcova1, Sabina Oreska1, Hana Wunsch1
1Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
Rheumatology (Oxford, England)
|May 23, 2025
概括
软骨酸性蛋白-1 (CRTAC1) 水平在患有全身性硬化症 (SSc) 的患者,特别是患有间歇性肺病 (ILD) 的患者中较低. 这表明CRTAC1是SSc肺部参与的潜在生物标志物.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 生物标志物发现发现
背景情况:
- 间歇性肺病 (ILD) 是系统性硬化症 (SSc) 死亡的主要原因.
- 软骨酸性蛋白-1 (CRTAC1),是一种由膜类型-2上皮细胞分泌的蛋白质,正在作为肺部健康的潜在生物标志物进行研究.
- 在SSc的背景下CRTAC1的作用,特别是在肺部并发症方面,需要进一步阐明.
研究的目的:
- 研究CRTAC1系统水平与系统性硬化症 (SSc) 之间的关联.
- 探索CRTAC1作为SSc患者肺部参与的生物标志物的潜力.
- 为了将CRTAC1水平与SSc.中的疾病活性和严重程度相关联.
主要方法:
- 从76名SSc患者和89名健康对照 (HC) 收集了血样本.
- 临床评估包括欧洲结核病研究小组 (ESSG) 活动评分,修改的罗丹皮肤评分 (mRSS),肺功能测试 (FVC,FEV1,DLCO) 和梅斯格尔疾病严重程度量表 (DSS).
- 使用CRTAC1智商-ELISA技术量化CRTAC1水平.
主要成果:
- 与HC相比,SSc患者的CRTAC1血水平显著较低 (P < 0.001).
- 患有ILD的SSc患者的CRTAC1水平比没有ILD的患者低 (P = 0.027).
- CRTAC1水平与DSS肺部干扰和ESSG活动得分负相关,与DLCO,FEV1和FVC积极相关. 在患有胃肠道,关节参与和肺动脉高血压的患者中也观察到CRTAC1的降低.
结论:
- 在SSc患者中,全身CRTAC1水平降低,特别是在ILD和肺功能降低患者中.
- 在系统性硬化症中,CRTAC1显示出作为评估肺部参与和疾病活动的有价值生物标志物的潜力.
- 需要进一步的研究来探索CRTAC1在SSc中的诊断和预后能力.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
73
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
73
Cardiomyopathy IV: Restrictive Cardiomyopathy
46
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
46
Chronic Obstructive Pulmonary Disease
1.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K
COPD: Pathogenesis and Clinical Features
551
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
551
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


